foscarnet has been researched along with Pancytopenia in 4 studies
Foscarnet: An antiviral agent used in the treatment of cytomegalovirus retinitis. Foscarnet also shows activity against human herpesviruses and HIV.
phosphonoformic acid : Phosphoric acid in which one of the hydroxy groups is replaced by a carboxylic acid group. It is used as the trisodium salt as an antiviral agent in the treatment of cytomegalovirus retinitis (CMV retinitis, an inflamation of the retina that can lead to blindness) and as an alternative to ganciclovir for AIDS patients who require concurrent antiretroviral therapy but are unable to tolerate ganciclovir due to haematological toxicity.
Pancytopenia: Deficiency of all three cell elements of the blood, erythrocytes, leukocytes and platelets.
Excerpt | Relevance | Reference |
---|---|---|
" Immunosuppressive therapy was reduced, and the patient was treated with foscarnet for 2 weeks, leading to a dramatic normalization of blood cell counts, concomitantly with the disappearance of HHV-8 viremia." | 7.71 | Severe pancytopenia and hemophagocytosis after HHV-8 primary infection in a renal transplant patient successfully treated with foscarnet. ( Barozzi, P; Facchetti, F; Luppi, M; Rasini, V; Re, A; Riva, G; Rossi, G; Sandrini, S; Setti, G; Torelli, G, 2002) |
" Immunosuppressive therapy was reduced, and the patient was treated with foscarnet for 2 weeks, leading to a dramatic normalization of blood cell counts, concomitantly with the disappearance of HHV-8 viremia." | 3.71 | Severe pancytopenia and hemophagocytosis after HHV-8 primary infection in a renal transplant patient successfully treated with foscarnet. ( Barozzi, P; Facchetti, F; Luppi, M; Rasini, V; Re, A; Riva, G; Rossi, G; Sandrini, S; Setti, G; Torelli, G, 2002) |
"Persistent erythema multiforme is a rare disorder with only 23 known cases reported in the literature." | 1.34 | Persistent erythema multiforme and CMV infection. ( Grossman, ME; Hinds, G; Husain, S; Hutt, C; Pol-Rodriguez, M; Wanner, M, 2007) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Weinkove, R | 1 |
Dickson, M | 1 |
Eliadou, E | 1 |
Stace, NH | 1 |
Goossens, L | 1 |
Ferguson, P | 1 |
Luppi, M | 1 |
Barozzi, P | 1 |
Rasini, V | 1 |
Riva, G | 1 |
Re, A | 1 |
Rossi, G | 1 |
Setti, G | 1 |
Sandrini, S | 1 |
Facchetti, F | 1 |
Torelli, G | 1 |
Wanner, M | 1 |
Pol-Rodriguez, M | 1 |
Hinds, G | 1 |
Hutt, C | 1 |
Husain, S | 1 |
Grossman, ME | 1 |
Willocks, L | 1 |
Brettle, R | 1 |
4 other studies available for foscarnet and Pancytopenia
Article | Year |
---|---|
Fever and pancytopenia in a patient with Crohn's disease.
Topics: Angiography; Antiviral Agents; Azathioprine; Cecum; Crohn Disease; Digestive System Surgical Procedu | 2013 |
Severe pancytopenia and hemophagocytosis after HHV-8 primary infection in a renal transplant patient successfully treated with foscarnet.
Topics: Antiviral Agents; DNA, Viral; Foscarnet; Herpesvirus 8, Human; Humans; Kidney Transplantation; Male; | 2002 |
Persistent erythema multiforme and CMV infection.
Topics: Antiviral Agents; Bone Marrow Diseases; Cytomegalovirus Infections; Erythema Multiforme; Fatal Outco | 2007 |
Foscarnet and pancytopenia.
Topics: Adult; Antiviral Agents; Foscarnet; Humans; Pancytopenia; Phosphonoacetic Acid | 1992 |